Pure total flavonoids from citrus attenuate non-alcoholic steatohepatitis via regulating the gut microbiota and bile acid metabolism in mice

被引:45
作者
He, Beihui [1 ]
Jiang, Jianping [1 ,2 ]
Shi, Zheng [3 ]
Wu, Liyan [4 ]
Yan, Junbin [1 ]
Chen, Zheng [1 ]
Luo, Minmin [1 ]
Cui, Dawei [5 ]
Xu, Sumei [6 ]
Yan, Maoxiang [1 ]
Zhang, Shuo [7 ]
Chen, Zhiyun [1 ]
机构
[1] Zhejiang Chinese Med Univ, Key Lab Integrat Chinese & Western Med Diag & Tre, Cent Lab 2, Affiliated Hosp 1, Hangzhou 310006, Peoples R China
[2] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Preparat Ctr, Hangzhou 310006, Peoples R China
[3] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Pharm, Hangzhou 310006, Peoples R China
[4] Tongde Hosp Zhejiang Prov, Dept Gastroenterol, Hangzhou 310012, Peoples R China
[5] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Blood Transfus, Hangzhou 310003, Peoples R China
[6] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Gen Family Med, Hangzhou 310006, Peoples R China
[7] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou 310006, Peoples R China
基金
中国国家自然科学基金;
关键词
Pure total flavonoids from citrus; Non-alcoholic steatohepatitis; Gut microbiota; Bile acid; FXR; TGR5;
D O I
10.1016/j.biopha.2020.111183
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Our previous studies found that Pure total flavnoids from citrus (PTFC) can effectively improve nonalcoholic steatohepatitis (NASH) in mice. Here, we discuss on the mechanism of PTFC in treating NASH with focus on the regulation of the gut microbiota and bile acid metabolism. Methods: C57BL/6 J mice were randomly divided into three groups: normal diet group (Normal), high-fat diet group (HFD) and high-fat + PTFC treatment group (PTFC). Mice in the Normal group were fed chow diet, while the other groups were fed high fat diet (HFD) for 16 weeks. In the 5th week, the mice in the PTFC group were treated with 50 mg/kg/day PTFC for an additional twelve weeks. After sacrifice, histopathology of the liver was assessed, and the gut microbial composition was analyzed by 16S rDNA gene sequencing. Bile Acid profiles in serum were determined by ultraperformance liquid chromatography (UPLC-MS/MS). Results: PTFC intervention significantly attenuated HFD-induced NASH symptoms compared with the HFD group in mice. 16S rDNA sequencing showed that PTFC treatment increased the phylogenetic diversity of the HFDinduced microbiota dysbiosis. PTFC intervention significantly increased the relative abundances of Bacteroidaceae and Christensenellaceae. Furthermore, PTFC reduced the content of toxic bile acids, such as TDCA, DCA, TCA, CA and increased the ratio of secondary to primary bile acids. FXR and TGR5 deficiency were significantly alleviated. Conclusion: PTFC can improve NASH via the the gut microbiota and bile acid metabolism.
引用
收藏
页数:15
相关论文
共 37 条
[1]   Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease [J].
Aragones, Gemma ;
Gonzalez-Garcia, Sergio ;
Aguilar, Carmen ;
Richart, Cristobal ;
Auguet, Teresa .
BIOMED RESEARCH INTERNATIONAL, 2019, 2019
[2]   Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease [J].
Chavez-Talavera, Oscar ;
Tailleux, Anne ;
Lefebvre, Philippe ;
Staels, Bart .
GASTROENTEROLOGY, 2017, 152 (07) :1679-+
[3]  
Chen T., 2019, MOLECULES BASEL SWIT, V24
[4]  
Chen Z.Y, 2014, J CHIN MAT MED, V39, P100
[5]   Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis [J].
Chiu, Chien-Chao ;
Ching, Yung-Hao ;
Li, Yen-Peng ;
Liu, Ju-Yun ;
Huang, Yen-Te ;
Huang, Yi-Wen ;
Yang, Sien-Sing ;
Huang, Wen-Ching ;
Chuang, Hsiao-Li .
NUTRIENTS, 2017, 9 (11)
[6]   Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study [J].
Depommier, Clara ;
Everard, Amandine ;
Druart, Celine ;
Plovier, Hubert ;
Van Hul, Matthias ;
Vieira-Silva, Sara ;
Falony, Gwen ;
Raes, Jeroen ;
Maiter, Dominique ;
Delzenne, Nathalie M. ;
de Barsy, Marie ;
Loumaye, Audrey ;
Hermans, Michel P. ;
Thissen, Jean-Paul ;
de Vos, Willem M. ;
Cani, Patrice D. .
NATURE MEDICINE, 2019, 25 (07) :1096-+
[7]   Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss [J].
Dixon, JB ;
Bhathal, PS ;
Hughes, NR ;
O'Brien, PE .
HEPATOLOGY, 2004, 39 (06) :1647-1654
[8]   Nonalcoholic Fatty Liver Disease in Adolescents and Young Adults: The Next Frontier in the Epidemic [J].
Doycheva, Iliana ;
Watt, Kymberly D. ;
Alkhouri, Naim .
HEPATOLOGY, 2017, 65 (06) :2100-2109
[9]   Intestinal TGR5 agonism improves hepatic steatosis and insulin sensitivity in Western diet-fed mice [J].
Finn, Patricia D. ;
Rodriguez, David ;
Kohler, Jill ;
Jiang, Zhengfeng ;
Wan, Sindy ;
Blanco, Erick ;
King, Andrew J. ;
Chen, Tao ;
Bell, Noah ;
Dragoli, Dean ;
Jacobs, Jeffrey W. ;
Jain, Rakesh ;
Leadbetter, Michael ;
Siegel, Matthew ;
Carreras, Christopher W. ;
Koo-McCoy, Samantha ;
Shaw, Karen ;
Le, Cathy ;
Vanegas, Sandra ;
Hsu, I-Hsin ;
Kozuka, Kenji ;
Okamoto, Keiko ;
Caldwell, Jeremy S. ;
Lewis, Jason G. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2019, 316 (03) :G412-G424
[10]  
Hibberd AA, 2019, BENEF MICROBES, V10, P121, DOI [10.3920/BM2018.0028, 10.3920/bm2018.0028]